Abstract

Toxoplasma gondii has a remarkable ability to infect an enormous variety of mammalian and avian species. Given this, it is surprising that three strains (Types I/II/III) account for the majority of isolates from Europe/North America. The selective pressures that have driven the emergence of these particular strains, however, remain enigmatic. We hypothesized that strain selection might be partially driven by adaptation of strains for mammalian versus avian hosts. To test this, we examine in vitro, strain-dependent host responses in fibroblasts of a representative avian host, the chicken (Gallus gallus). Using gene expression profiling of infected chicken embryonic fibroblasts and pathway analysis to assess host response, we show here that chicken cells respond with distinct transcriptional profiles upon infection with Type II versus III strains that are reminiscent of profiles observed in mammalian cells. To identify the parasite drivers of these differences, chicken fibroblasts were infected with individual F1 progeny of a Type II x III cross and host gene expression was assessed for each by microarray. QTL mapping of transcriptional differences suggested, and deletion strains confirmed, that, as in mammalian cells, the polymorphic rhoptry kinase ROP16 is the major driver of strain-specific responses. We originally hypothesized that comparing avian versus mammalian host response might reveal an inversion in parasite strain-dependent phenotypes; specifically, for polymorphic effectors like ROP16, we hypothesized that the allele with most activity in mammalian cells might be less active in avian cells. Instead, we found that activity of ROP16 alleles appears to be conserved across host species; moreover, additional parasite loci that were previously mapped for strain-specific effects on mammalian response showed similar strain-specific effects in chicken cells. These results indicate that if different hosts select for different parasite genotypes, the selection operates downstream of the signaling occurring during the beginning of the host's immune response.

Highlights

  • The Apicomplexan parasite Toxoplasma gondii is unique among known eukaryotic pathogens in its extraordinarily broad host range

  • Analysis of Microarrays (SAM) identified 432 genes that were significantly up-regulated ($1.5-fold-change and false-discovery rate (FDR),5%) in cells infected with Type III versus Type II strains, and 450 genes that were significantly upregulated by the same criteria in Type II versus Type III infections (Figure 1A and B)

  • Contrary to our original prediction, straindependent differences in the response of chicken embryonic fibroblasts (CEFs) to infection by Type II and Type III strains exhibit broadly similar patterns to those previously reported in murine macrophages and human fibroblasts

Read more

Summary

Introduction

The Apicomplexan parasite Toxoplasma gondii is unique among known eukaryotic pathogens in its extraordinarily broad host range In vitro, it can infect virtually any eukaryotic cell; its only known definitive hosts are felines, Toxoplasma’s known intermediate hosts include a wide range of warm-blooded vertebrates around the world, from avians to mammals. If the response to infection is too weak and parasites are allowed to proliferate unchecked, the infection will overwhelm the host; but if the immune response to infection is too robust, it can lead to host immunopathology. The importance of this balance has been underscored by several studies examining the role of various host immune factors in resistance to infection. In the converse scenario, where mice are deficient in key regulatory cytokines such as IL-10 and IL-27, immunopathology resulting from infection is increased [2,3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call